These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28653044)

  • 1. Neuroclinical Framework for the Role of Stress in Addiction.
    Kwako LE; Koob GF
    Chronic Stress (Thousand Oaks); 2017 Feb; 1():. PubMed ID: 28653044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
    Koob GF
    Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addiction as a stress surfeit disorder.
    Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addiction is a Reward Deficit and Stress Surfeit Disorder.
    Koob GF
    Front Psychiatry; 2013; 4():72. PubMed ID: 23914176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging pharmacotherapies for alcohol use disorder.
    Mason BJ
    Neuropharmacology; 2017 Aug; 122():244-253. PubMed ID: 28454983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dark side of emotion: the addiction perspective.
    Koob GF
    Eur J Pharmacol; 2015 Apr; 753():73-87. PubMed ID: 25583178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.
    Votaw VR; Pearson MR; Stein E; Witkiewitz K
    Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.
    Kwako LE; Momenan R; Litten RZ; Koob GF; Goldman D
    Biol Psychiatry; 2016 Aug; 80(3):179-89. PubMed ID: 26772405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existing and Future Drugs for the Treatment of the Dark Side of Addiction.
    Koob GF; Mason BJ
    Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.
    Koob GF; Colrain IM
    Neuropsychopharmacology; 2020 Jan; 45(1):141-165. PubMed ID: 31234199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.
    Votaw VR; Boness CL; Stein ER; Watts AL; Sher KJ; Witkiewitz K
    Exp Clin Psychopharmacol; 2024 Feb; 32(1):68-83. PubMed ID: 37227882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiological mechanisms and related clinical treatment of addiction: a review.
    Fang Y; Sun Y; Liu Y; Liu T; Hao W; Liao Y
    Psychoradiology; 2022 Dec; 2(4):180-189. PubMed ID: 38665277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine.
    Nieto SJ; Ray LA
    Behav Brain Res; 2022 Jun; 427():113876. PubMed ID: 35378110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction and stress: An allostatic view.
    Koob GF; Schulkin J
    Neurosci Biobehav Rev; 2019 Nov; 106():245-262. PubMed ID: 30227143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual differences in the neuropsychopathology of addiction.
    George O; Koob GF
    Dialogues Clin Neurosci; 2017 Sep; 19(3):217-229. PubMed ID: 29302219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.
    Koob GF
    Curr Top Behav Neurosci; 2022; 58():147-165. PubMed ID: 35112332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addictions Neuroclinical Assessment: A reverse translational approach.
    Kwako LE; Momenan R; Grodin EN; Litten RZ; Koob GF; Goldman D
    Neuropharmacology; 2017 Aug; 122():254-264. PubMed ID: 28283392
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.